Challenges in the development and use of pharmacogenomic markers in oncology.
Innocenti
Federico
F
Section of Hematology/Oncology, Department of Medicine, Cancer Research Center, University of Chicago, Illinois 60637, USA. finnocen@medicine.bsd.uchicago.edu
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005819:Genetic Markers; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics*; D010597:Pharmacogenetics / Q000379:methods*
D000970:Antineoplastic Agents; D005819:Genetic Markers